|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Arnold M, Soerjomataram I, Ferlay J and
Forman D: Global incidence of oesophageal cancer by histological
subtype in 2012. GUT. 64:381–387. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Abbasi BA, Iqbal J, Ahmad R, Bibi S,
Mahmood T, Kanwal S, Bashir S, Gul F and Hameed S: Potential
phytochemicals in the prevention and treatment of esophagus cancer:
A green therapeutic approach. Pharmacol Rep. 71:644–652. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang Y: Epidemiology of esophageal
cancer. World J Gastroenterol. 19:5598–5606. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Napier KJ, Scheerer M and Misra S:
Esophageal cancer: A Review of epidemiology, pathogenesis, staging
workup and treatment modalities. World J Gastrointest Oncol.
6:112–120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mir MM and Dar NA: Esophageal cancer in
kashmir (India): An enigma for researchers. Int J Health Sci
(Qassim). 3:71–85. 2009.PubMed/NCBI
|
|
7
|
Wong M, Hamilton W, Whiteman DC, Jiang JY,
Qiao Y, Fung F, Wang H, Chiu P, Ng E, Wu J, et al: Global Incidence
and mortality of oesophageal cancer and their correlation with
socioeconomic indicators temporal patterns and trends in 41
countries. Sci Rep. 8:45222018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nan L, Wei J, Jacko AM, Culley MK, Zhao J,
Natarajan V, Ma H and Zhao Y: Cross-talk between lysophosphatidic
acid receptor 1 and tropomyosin receptor kinase A promotes lung
epithelial cell migration. Biochim Biophys Acta. 1863:229–235.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tripathi V, Shin JH, Stuelten CH and Zhang
YE: TGF-β-induced alternative splicing of TAK1 promotes EMT and
drug resistance. Oncogene. 38:3185–3200. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ota I, Masui T, Kurihara M, Yook JI,
Mikami S, Kimura T, Shimada K, Konishi N, Yane K, Yamanaka T and
Kitahara T: Snail-induced EMT promotes cancer stem cell-like
properties in head and neck cancer cells. Oncol Rep. 35:261–266.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mooney SM, Talebian V, Jolly MK, Jia D,
Gromala M, Levine H and McConkey BJ: The GRHL2/ZEB feedback loop-a
key axis in the regulation of EMT in breast cancer. J Cell Biochem.
118:2559–2570. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cano A and Portillo F: An emerging role
for class I bHLH E2-2 proteins in EMT regulation and tumor
progression. Cell Adh Migr. 4:56–60. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gao FX, Wu J and Ren DL: Effect of
epithelial-to-mesenchymal transition on biological activity of NK
cells in esophageal squamous cell carcinoma. Sichuan Da Xue Xue Bao
Yi Xue Ban. 50:40–47. 2019.(In Chinese). PubMed/NCBI
|
|
14
|
Yokozaki H, Koma YI, Shigeoka M and Nishio
M: Cancer as a tissue: The significance of cancer-stromal
interactions in the development, morphogenesis and progression of
human upper digestive tract cancer. Pathol Int. 68:334–352. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mladinich M, Ruan D and Chan CH: Tackling
cancer stem cells via inhibition of EMT transcription factors. Stem
Cells Int. 2016:52858922016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pattabiraman DR, Bierie B, Kober KI, Thiru
P, Krall JA, Zill C, Reinhardt F, Tam WL and Weinberg RA:
Activation of PKA leads to mesenchymal-to-epithelial transition and
loss of tumor-initiating ability. Science. 351:d36802016.
View Article : Google Scholar
|
|
17
|
Gugnoni M, Sancisi V, Gandolfi G, Manzotti
G, Ragazzi M, Giordano D, Tamagnini I, Tigano M, Frasoldati A,
Piana S and Ciarrocchi A: Cadherin-6 promotes EMT and cancer
metastasis by restraining autophagy. Oncogene. 36:667–677. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ouyang F, Huang H, Zhang M, Chen M, Huang
H, Huang F and Zhou S: HMGB1 induces apoptosis and EMT in
association with increased autophagy following H/R injury in
cardiomyocytes. Int J Mol Med. 37:679–689. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lin R, Zhang Z, Chen L, Zhou Y, Zou P,
Feng C, Wang L and Liang G: Dihydroartemisinin (DHA) induces
ferroptosis and causes cell cycle arrest in head and neck carcinoma
cells. Cancer Lett. 381:165–175. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu T, Guo J, Wang T, Zhang S, Yu X, Hou C
and Guo D: Network pharmacology-based analysis of mechanisms of the
anti-hepatocellular carcinoma effect by dihydroartemisinin. Discov
Med. 28:139–147. 2019.PubMed/NCBI
|
|
21
|
Daugaard I, Sanders KJ, Idica A,
Vittayarukskul K, Hamdorf M, Krog JD, Chow R, Jury D, Hansen LL,
Hager H, et al: miR-151a induces partial EMT by regulating
E-cadherin in NSCLC cells. Oncogenesis. 6:e3662017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang X, Liu G, Kang Y, Dong Z, Qian Q and
Ma X: N-cadherin expression is associated with acquisition of EMT
phenotype and with enhanced invasion in erlotinib-resistant lung
cancer cell lines. PLoS One. 8:e576922013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ivaska J: Vimentin: Central hub in EMT
induction? Small GTPases. 2:51–53. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liang P, Jiang B, Li Y, Liu Z, Zhang P,
Zhang M, Huang X and Xiao X: Autophagy promotes angiogenesis via
AMPK/Akt/mTOR signaling during the recovery of heat-denatured
endothelial cells. Cell Death Dis. 9:11522018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang J, Pi C and Wang G: Inhibition of
PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy
in hepatocellular carcinoma cells. Biomed Pharmacother.
103:699–707. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fan S, Zhang B, Luan P, Gu B, Wan Q, Huang
X, Liao W and Liu J: PI3K/AKT/mTOR/p70S6K pathway is involved in
Aβ25-35-induced autophagy. Biomed Res Int. 2015:1610202015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cao P, Leng D, Li Y, Zhang Z, Liu L and Li
X: Progress on anti-tumor molecular mechanisms of
dihydroartemisinin. Zhejiang Da Xue Xue Bao Yi Xue Ban. 45:501–507.
2016.(In Chinese). PubMed/NCBI
|
|
28
|
Zhang CZ, Zhang H, Yun J, Chen GG and Lai
PB: Dihydroartemisinin exhibits antitumor activity toward
hepatocellular carcinoma in vitro and in vivo.
Biochem Pharmacol. 83:1278–1289. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Thongchot S, Vidoni C, Ferraresi A,
Loilome W, Yongvanit P, Namwat N and Isidoro C: Dihydroartemisinin
induces apoptosis and autophagy-dependent cell death in
cholangiocarcinoma through a DAPK1-BECLIN1 pathway. Mol Carcinog.
57:1735–1750. 2018. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li X, Ba Q, Liu Y, Yue Q, Chen P, Li J,
Zhang H, Ying H, Ding Q, Song H, et al: Dihydroartemisinin
selectively inhibits PDGFRalpha-positive ovarian cancer growth and
metastasis through inducing degradation of PDGFRalpha protein. Cell
Discov. 3:170422017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shi X, Wang L, Li X, Bai J, Li J, Li S,
Wang Z and Zhou M: Dihydroartemisinin induces autophagy-dependent
death in human tongue squamous cell carcinoma cells through DNA
double-strand break-mediated oxidative stress. Oncotarget.
8:45981–45993. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jiang J, Geng G, Yu X, Liu H, Gao J, An H,
Cai C, Li N, Shen D, Wu X, et al: Repurposing the anti-malarial
drug dihydroartemisinin suppresses metastasis of non-small-cell
lung cancer via inhibiting NF-kappaB/GLUT1 axis. Oncotarget.
7:87271–87283. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Im E, Yeo C, Lee HJ and Lee EO:
Dihydroartemisinin induced caspase-dependent apoptosis through
inhibiting the specificity protein 1 pathway in hepatocellular
carcinoma SK-Hep-1 cells. Life Sci. 192:286–292. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li Y, Sui H, Jiang C, Li S, Han Y, Huang
P, Du X, Du J and Bai Y: Dihydroartemisinin increases the
sensitivity of photodynamic therapy via NF-κB/HIF-1α/VEGF pathway
in esophageal cancer cell in vitro and in vivo. Cell
Physiol Biochem. 48:2035–2045. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jiang C, Li S, Li Y and Bai Y: Anticancer
effects of dihydroartemisinin on human esophageal cancer cells
in vivo. Anal Cell Pathol (Amst).
2018:87597452018.PubMed/NCBI
|
|
36
|
Li S, Huang P, Gan J, Ling X, Du X, Liao
Y, Li L, Meng Y, Li Y and Bai Y: Dihydroartemisinin represses
esophageal cancer glycolysis by down-regulating pyruvate kinase M2.
Eur J Pharmacol. 854:232–239. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li YJ, Zhou JH, Du XX, Jia DX, Wu CL,
Huang P, Han Y, Sui H, Wei XL, Liu L, et al: Dihydroartemisinin
accentuates the anti-tumor effects of photodynamic therapy via
inactivation of NF-κB in Eca109 and Ec9706 esophageal cancer cells.
Cell Physiol Biochem. 33:1527–1536. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Du XX, Li YJ, Wu CL, Zhou JH, Han Y, Sui
H, Wei XL, Liu L, Huang P, Yuan HH, et al: Initiation of apoptosis,
cell cycle arrest and autophagy of esophageal cancer cells by
dihydroartemisinin. Biomed Pharmacother. 67:417–424. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Alonso-Alconada L, Eritja N, Muinelo-Romay
L, Barbazan J, Lopez-Lopez R, Matias-Guiu X, Gil-Moreno A, Dolcet X
and Abal M: ETV5 transcription program links BDNF and promotion of
EMT at invasive front of endometrial carcinomas. Carcinogenesis.
35:2679–2686. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhou S, Zhao L, Kuang M, Zhang B, Liang Z,
Yi T, Wei Y and Zhao X: Autophagy in tumorigenesis and cancer
therapy: Dr. Jekyll or Mr. Hyde? Cancer Lett. 323:115–127. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Colella B, Faienza F and Di Bartolomeo S:
EMT regulation by autophagy: A new perspective in glioblastoma
biology. Cancers (Basel). 11:3122019. View Article : Google Scholar
|
|
42
|
Feng H, Zhao X, Guo Q, Feng Y, Ma M, Guo
W, Dong X, Deng C, Li C, Song X, et al: Autophagy resists EMT
process to maintain retinal pigment epithelium homeostasis. Int J
Biol Sci. 15:507–521. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li J, Yang B, Zhou Q, Wu Y, Shang D, Guo
Y, Song Z, Zheng Q and Xiong J: Autophagy promotes hepatocellular
carcinoma cell invasion through activation of
epithelial-mesenchymal transition. Carcinogenesis. 34:1343–1351.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Park S, Ha SD, Coleman M, Meshkibaf S and
Kim SO: p62/SQSTM1 enhances NOD2-mediated signaling and cytokine
production through stabilizing NOD2 oligomerization. PLoS One.
8:e571382013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Qiang L, Zhao B, Ming M, Wang N, He TC,
Hwang S, Thorburn A and He YY: Regulation of cell proliferation and
migration by p62 through stabilization of Twist1. Proc Natl Acad
Sci USA. 111:9241–9246. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Qiang L and He YY: Autophagy deficiency
stabilizes TWIST1 to promote epithelial-mesenchymal transition.
Autophagy. 10:1864–1865. 2014. View Article : Google Scholar : PubMed/NCBI
|
